Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 1 Year to 12

Propofol-only vs dexmedetomidine-propofol for sedation in children undergoing MRI

Official title: A Randomized, Dose-Ranging Trial of Propofol-Only and Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging

Run by Boston Children's Hospital · NCT07369128 · Data updated 2026-11-12

This study tests whether using dexmedetomidine with propofol works better or differently than propofol alone for sedating kids during MRI.

More Dexmedetomidine trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages1 Year to 12 Years
SexAll
Enrollment105 (estimated)
SponsorBoston Children's Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedJune 30, 2026
Main results expectedDecember 2027
Study endsMarch 2028
Registry record updatedSeptember 21, 2026
Trial IDNCT07369128 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Outpatients aged 1–12 years scheduled for MRI with a natural airway and ASA I–III, suitable for the described sedation technique.

Probably not a fit

Children not matching the inclusion criteria or with contraindications to propofol or dexmedetomidine may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional phase 4 trial compares two sedation regimens for pediatric MRI: propofol alone versus a combination of dexmedetomidine and propofol. Children aged 1 to 12 years requiring MRI and with a suitable airway are enrolled and randomized to receive either regimen, with dosing strategies including IV dexmedetomidine and propofol as specified. The study aims to assess outcomes such as emergence behavior, recovery time, and safety in a real-world outpatient setting at Boston Children’s Hospital. The approach builds on prior evidence suggesting dexmedetomidine may reduce airway events and potentially offer neuroprotective advantages compared with propofol alone. Results could inform optimal sedation strategies for pediatric MRI procedures.

Why it matters

Potential benefit: If successful, the regimen could provide safer sedation with smoother recovery for pediatric MRI patients.

How similar studies have gone: Previous work suggests dexmedetomidine combinations may offer advantages over propofol alone, but robust phase 4 confirmation is needed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients presenting as outpatients, scheduled to receive an anesthetic for MRI of brain, body (spine, chest, abdomen, and/or pelvis) and/or extremity (arm and/or leg).
* Patients must be a candidate for the sedation technique described in this study with a natural airway. This decision will be made by a staff member of the Department of Anesthesiology.
* Between 1 and 12 years of age.
* ASA status I, II, or III

Exclusion Criteria:

* Inpatient at BCH
* Diagnosis of a difficult airway, severe obstructive sleep apnea that is not compatible with spontaneous ventilation in a supine position, or requires an oral airway.
* Congenital heart disease or history of dysrhythmia.
* Taking digoxin or beta-blocker
* Anxiolytic medication is ordered before the MRI (e.g., midazolam or ketamine).
* History or a family (parent or sibling) history of malignant hyperthermia.
* Allergy to or has a contraindication to propofol, lidocaine, or dexmedetomidine.
* Tracheostomy or other mechanical airway device present
* Received within the past 12 hours an oral or intravenous alpha-adrenergic, beta-adrenergic agonist, or antagonist drugs (e.g., clonidine, propranolol, albuterol).
* Patient is not scheduled to receive anesthesia-sedation care or is noted to "try-without anesthesia" for the MRI
* Patient has significant developmental or psychological delays
* Patient scheduled for scan of duration \<30 minutes or \>90 minutes

Where it's running

  • Boston Children's Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.